Metformin-induced reductions in tumor growth involves modulation of the gut microbiome
Open Access
- 20 April 2022
- journal article
- research article
- Published by Elsevier in Molecular Metabolism
- Vol. 61, 101498
Abstract
No abstract availableKeywords
Funding Information
- Canada Research Chairs
- Canadian Diabetes Association (DI-5-17-5302-GS)
- Canadian Cancer Society
- Diabetes Canada
- Canadian Institutes of Health Research (201709FDN-CEBA-116200)
- Canadian Institutes of Health Research (144625-1)
This publication has 58 references indexed in Scilit:
- High-Fat Diet Reduces the Formation of Butyrate, but Increases Succinate, Inflammation, Liver Fat and Cholesterol in Rats, while Dietary Fibre Counteracts These EffectsPLOS ONE, 2013
- Gut metagenome in European women with normal, impaired and diabetic glucose controlNature, 2013
- phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census DataPLOS ONE, 2013
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Generation of Multimillion-Sequence 16S rRNA Gene Libraries from Complex Microbial Communities by Assembling Paired-End Illumina ReadsApplied and Environmental Microbiology, 2011
- Understanding the benefit of metformin use in cancer treatmentBMC Medicine, 2011
- Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivoOncogene, 2010
- Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short‐chain fatty acidsIUBMB Life, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003